Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;24(3):405-419.
doi: 10.1016/j.cld.2020.04.008. Epub 2020 Apr 13.

Viral Hepatitis Other than A, B, and C: Evaluation and Management

Affiliations
Review

Viral Hepatitis Other than A, B, and C: Evaluation and Management

Amanda Cheung et al. Clin Liver Dis. 2020 Aug.

Abstract

Viral hepatitis can cause a wide spectrum of clinical presentations from a benign form with minimal or no symptoms to acute liver failure or death. Hepatitis D coinfection and superinfection have distinct clinical courses, with the latter more likely leading to chronic infection. Management of chronic hepatitis D virus is individualized because of the paucity of treatment options and significant side effect profile of currently available treatments. Sporadic cases of hepatitis E caused by contaminated meats are becoming increasingly prevalent in immunocompromised hosts. Human herpesviruses are an important cause of disease also in immunocompromised individuals.

Keywords: Hepatitis D; Hepatitis E; Hepatotropic viruses; Human herpesvirus; Viral hepatitis.

PubMed Disclaimer

Conflict of interest statement

Disclosure A. Cheung has nothing to disclose. P. Kwo has received grant support from Eiger.

Figures

Fig. 1
Fig. 1
Typical pattern of HBV and HDV serologies in HDV infection. Coinfection leads to clearance of both viruses in 95% of patients. Superinfection in a patient with preexisting chronic HBV infection most often leads to chronic HDV infection. HBcAb, hepatitis B core antibody; HBsAb, hepatitis B surface antibody; IgG, immunoglobulin G; IgM, immunoglobulin M.

References

    1. Rizzetto M., Canese M.G., Aricò S. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977;18(12):997–1003. - PMC - PubMed
    1. Heller T., Koh C., Glenn J.S. Hepatitis D. In: Sanyal A., Boyer T., Lindor K., editors. Zakim and Boyer's hepatology: a textbook of liver disease. 7th edition. Elsevier; Philadelphia: 2018. pp. 501–511.
    1. Lin H.H., Lee S.S., Yu M.L. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program. Hepatology. 2015;61(6):1870–1879. - PubMed
    1. Chen H.Y., Shen D., Ji D. Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis. Gut. 2019;68:512–521. - PubMed
    1. Caredda F., Rossi E., d'Arminio Monforte A. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome. J Infect Dis. 1985;151(5):925–928. - PubMed

MeSH terms